Skip to main content
HeartCited

Selenium für Coronary Artery Disease (CAD)

C Evidenz Begrenzte Evidenz aus kleinen Studien, aber es gibt einige positive Signale.

SELECT trial was negative as monotherapy. KiSel-10 was positive in combination with CoQ10. U-shaped dose response — research suggests benefit only in deficient populations (serum <100 mcg/L).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dselenium\u0026condition\u003Dcoronary\u002Dartery\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Fazit

SELECT trial was negative as monotherapy. KiSel-10 was positive in combination with CoQ10. U-shaped dose response — research suggests benefit only in deficient populations (serum <100 mcg/L).

Key Study Findings

Controlled Clinical Trial
Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / …
Dose: None vs.: None Outcome: antioxidant status Wirkung: None p=0.001

Population: patients with depression

Review
Role of mercury toxicity in hypertension, cardiovascular disease, and stroke.
Dose: None vs.: None Outcome: blood pressure Wirkung: None None

Population: hypertension patients

Key Statistics

5

Studien

10000

Teilnehmer

Mixed

C

Bewertung

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
55 mcg/day
cardiovascularantioxidant:
100-200 mcg/day

Obergrenze: 400 mcg/day (risk of selenosis above this level)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Neutral --
None -- Positive --

Beste Einnahmezeit: With meals

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Selenosis at high doses (garlic breath odor, hair/nail loss, nausea)
  • GI discomfort at moderate-high doses
  • Potential increased type 2 diabetes risk at high supplemental doses

Bekannte Wechselwirkungen

  • Cisplatin and other chemotherapy drugs (may affect efficacy)
  • Statins (may enhance antioxidant effects)
  • CoQ10 (synergistic cardiovascular benefit — KiSel-10 combination)

Tolerierbare Höchstaufnahmemenge: 400 mcg/day (risk of selenosis above this level)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Selenium help with Coronary Artery Disease (CAD)?
Based on 5 studies with 10,000 participants, there is limited but promising evidence that Selenium may support Coronary Artery Disease (CAD) management. Our evidence grade is C (Some Evidence).
How much Selenium should I take for Coronary Artery Disease (CAD)?
Studies have used various dosages. A commonly studied range is 55 mcg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Selenium?
Reported side effects may include Selenosis at high doses (garlic breath odor, hair/nail loss, nausea), GI discomfort at moderate-high doses, Potential increased type 2 diabetes risk at high supplemental doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Selenium and Coronary Artery Disease (CAD)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 10,000 total participants. The overall direction of effect is mixed.

Andere Inhaltsstoffe für Coronary Artery Disease (CAD)

Selenium für andere Beschwerden

References

  1. [1] Mark C Houston. J Clin Hypertens (Greenwich). 2011. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. doi:10.1111/j.1751-7176.2011.00489.x PubMed
  2. [2] Michael Maes et al.. Neuro Endocrinol Lett. 2011. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway … PubMed

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.